Skip to content
Search

Latest Stories

FIP releases report on common ailment schemes across nations

Pharmacists played a vital role in managing the increasing demand for primary healthcare.

The International Pharmaceutical Federation (FIP) launched a report on pharmacy-led common ailment schemes.


The data was collected from 24 countries, including case studies from nine countries.

It highlighted the growing demand for care models for ageing populations and the increase in chronic non-communicable diseases.

Pharmacists had been managing the stress, including prescribing authority and provision of medicinal treatments.

Paul Sinclair AM, Global President of FIP, said, "I believe this report is both a foundation and a catalyst — a foundation on which FIP and our member organizations could base initial strategies and a catalyst to drive us to seek even more diverse and comprehensive insights in the future.

"By equipping pharmacists with the tools and knowledge they needed, we strived to ensure that patients had access to timely, informed, and personalized care."

The common ailment schemes offered improved access to care, enhanced patient quality of life, and cost-effective alternatives while reducing GP workloads.

However, operational challenges persisted due to inconsistencies in service requirements and stakeholder engagement, including variations in professional standards, formularies, geographical coverage, and remuneration pathways.

Public funding was the primary source of remuneration for these schemes, with additional training mandated in two-thirds of countries.

Community pharmacists worldwide offered early interventions for common conditions, capitalizing on their accessible locations, and benefiting patients.

The report talked about the existing models and encouraged FIP member organizations to promote pharmacy-based services.

FIP led in enhancing primary healthcare excellence and accessibility, endorsing the expansion of common ailment schemes to bolster healthcare access and system strength.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less